Find Academic Supervisors

• Medical Physiology
• Oxidative Stress and Inflammation
• Medical Education Research
• +2 more

Suzanne Estaphan is a Senior Lecturer in Medical Science (Physiology and Clinical Pharmacology) at the Australian National University (ANU) School of Medicine and Psychology . She holds qualifications including a Doctorate of Physiology (2015) , MSc in Physiology (2012) , MBBCh (2005) , and Basic Certificate in Medical Education (2018) . Her academic roles span curriculum development, admissions, and assessment committees in the ANU Medical School. Senior Lecturer, ANU (2023–present) Academic Editor, PLOS ONE (2024–present) Review Editor, Frontiers in Physiology (2023–present) Dr. Estaphan's research bridges oxidative stress and inflammation in disease pathology with medical education innovation . Her work explores antioxidant interventions for organ damage and investigates AI/virtual reality applications in education. Recent projects include studying sleep dysfunction in eating disorders and diabetes medication effects on exercise capacity . Between 2023–2025, her 15 most recent publications span oxidative stress , medical education , and molecular pathophysiology . Themes include homeostasis , clinical reasoning , and metabolic disorders , with subfields like MMP-9 biology , pancreatic injury , and VR-based hypoxia training . Scientific accolades include the American Physiological Society Travel Award (2017) and recognition as Senior Fellow of the Higher Education Academy (2023) . She mentors medical students, contributes to national physiology curriculum consensus projects, and has secured approximately $200,000 in research funding .

• Neuroscience
• Cognitive Science
• Pain Management
• +4 more

Associate Professor Ian Johnston is affiliated with the School of Psychology at The University of Sydney. His research focuses on neurocognitive effects of medical treatments, pain management, and behavioral interventions. Notable projects include investigations into chemotherapy-induced cognitive impairments and the psychological impacts of high-fat diets. He has contributed to systematic reviews and guidelines for harmonizing preclinical cancer research. Selected grants include a 2022 study on lifelong neurocognitive effects of adolescent diets and a 2020 grant funded by the Boyd Mervin Wilson bequest. His work spans interdisciplinary collaborations, with publications in journals like CyberPsychology, Behavior, and Social Networking and Neuroscience and Biobehavioral Reviews . Research interests integrate neuroscience, oncology, and behavioral science, addressing translational challenges in clinical and preclinical settings. His lab explores mechanisms linking inflammation, pain modulation, and cognitive decline in disease contexts.

• Sleep Disorders
• Obstructive Sleep Apnea
• Digital Health
• +7 more

Dr Bastien Lechat is a Research Fellow at Flinders Health and Medical Research Institute (FHMRI): Sleep Health, within the College of Medicine and Public Health at Flinders University. He is also a Full Member of the College of Science and Engineering and the Medical Device Research Institute. As an NHMRC Emerging Leadership Fellow, he leads innovative research at the intersection of sleep medicine, artificial intelligence, and wearable technology. Education: PhD in Sleep Health, Adelaide Institute for Sleep Health, Flinders University (2018–2021) Bachelor of Engineering in Engineering Science/Acoustics, Université du Maine, France (2014–2017) Dr Lechat’s research focuses on understanding the physiological mechanisms and consequences of obstructive sleep apnea (OSA), particularly night-to-night variability and patient subtypes. He develops AI-driven tools for efficient and accurate diagnosis using wearables and signal processing. His work aims to create a scalable, low-cost model of care for sleep-disordered breathing, addressing global diagnostic gaps. His recent publications reveal a strong trend in digital health innovation, with a focus on machine learning for OSA detection, circadian rhythm modeling, cardiovascular risk prediction, and climate impacts on sleep. His research has been published in top journals including Nature Communications , Journal of Sleep Research , and Sleep Medicine , demonstrating interdisciplinary reach. Scientific Awards and Recognition: NHMRC Emerging Leadership Fellow (2023) Helen Bearpark Memorial Scholarship (2022) Emerging Research Leader Award, Flinders University (2021) Multiple early-career awards from Sleep Down Under, Australasian Sleep Association, and Adelaide Sleep Retreat Ranked in the top 5% of international authors in sleep apnea by Expertscape Dr Lechat has secured over $2.5 million in competitive research funding and actively supervises and mentors junior researchers. He serves on the program committee of the American Thoracic Society meetings and contributes to clinical guidelines. He collaborates globally with industry and academic partners to translate research into clinical practice. Laboratories and Research Teams: He co-leads the 'Novel use of digital innovations & technology development' theme at FHMRI: Sleep Health, working closely with Professor Danny Eckert. His team integrates expertise in biomedical engineering, data science, and clinical sleep physiology to advance digital sleep medicine.

Antonio Verdejo-GarciaView profile

Professor

• Addiction
• Obesity
• Substance Abuse
• +5 more

Antonio Verdejo-Garcia is a Professor (Research) in the School of Psychological Sciences and the Turner Institute for Brain and Mental Health at Monash University. He holds an NHMRC Leadership Fellowship and serves as Co-Chair of the Neuroscience Interest Group at the International Society of Addiction Medicine. He has an Adjunct Honorary Appointment at Turning Point (Eastern Health). His academic journey includes a PhD from the University of Granada (2006) and postdoctoral training at Johns Hopkins University, University of Cambridge, and Institut Hospital del Mar d'Investigacions Mediques. Before joining Monash in 2012, he held roles as Lecturer, Senior Lecturer, and Associate Professor at the University of Granada. Research interests center on cognitive and neural mechanisms of executive control, decision-making, and their implications for addiction, compulsive eating, and obesity. He has authored over 290 peer-reviewed articles, edited a book on Cognition & Addiction, and secured continuous national/international research funding. His work has garnered over 17,000 citations. He serves on editorial boards for journals like Addiction , PLoS One , and Current Addiction Reports . Key projects include the AAT-APP Trial for alcohol use disorder, decoding drivers of food choices for obesity management, and neurocircuitry studies in addiction. Recent articles (2023–2025) focus on impulsivity, telehealth interventions for eating disorders, and neuropharmacological comparisons between MDMA and methamphetamine users. Scientific achievements include NHMRC Leadership Fellowship and contributions to clinical translation of cognitive rehabilitation. He advises on grants and mentors students in addiction neuroscience. Current projects involve psilocybin treatment for anorexia nervosa and cortical control of feeding circuits.

• Behavioral Neuroscience
• Cognitive Neuroscience
• Neural Basis of Decision-Making
• +5 more

Scientia Professor Bernard Balleine is a leading academic in behavioral and cognitive neuroscience at the University of New South Wales (UNSW Sydney) , affiliated with the School of Psychology . His career spans prestigious institutions including the University of Cambridge, University of California, Los Angeles (UCLA), and the University of Sydney. He has held senior research fellowships (e.g., NHMRC, NIMH) and directed research at UCLA’s Brain Research Institute. Education: BA (1st class honours, University Medal, University of Sydney, 1988), PhD (University of Cambridge, 1992) Research Interests: Balleine’s work focuses on the neural bases of goal-directed action, habit formation, and decision-making, with a strong emphasis on corticostriatal circuits, dopamine signaling, and motivational systems. His studies explore how predictive learning, reward processing, and neural plasticity interact to shape behavior, particularly in psychiatric and neurodegenerative disorders (e.g., addiction, OCD, Alzheimer’s). Scientific Trends: Recent publications analyze striatal dopamine dynamics, thalamostriatal pathways, and genetic models of cognitive dysfunction. His 2024 work highlights neural circuits governing action selection, while 2023 studies link TBI to apathy and Alzheimer’s to goal-directed impairments. Awards: Fellow of the American Psychological Association (2004), Australian Laureate Fellowship (2009), NHMRC Senior Principal Research Fellow (2015), NIMH Senior Investigator (2020) Grants & Collaborations: Funded by the Australian Research Council and NHMRC, with interdisciplinary collaborations in neuroethics, addiction studies, and cognitive neuropsychology. His lab integrates molecular, behavioral, and computational approaches to investigate neural mechanisms of action control.

• Supportive Cancer Care
• Microbiome Science
• Clinical Oncology
• +4 more

Associate Professor Hannah Wardill is an NHMRC EL2 Investigator at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences and SAHMRI. She leads the Supportive Oncology Research Group, focusing on improving cancer patients' health through innovative supportive care solutions. Her research spans microbiome science, clinical oncology, and genetic medicine, with landmark trials like CANCAN, GENESCREEN, and MYWELL. Education: PhD in Biomedicine from the University of Adelaide (2016), followed by a CJ Martin Fellowship at the University of Groningen (Netherlands). Current roles include Vice Chair of MASCC's Mucositis Study Group and Chair of the Cancer Symptoms Trials Group's Gut Dysfunction Node. Research interests center on mitigating long-term effects of cancer treatment, including chemotherapy-induced side effects, microbiota dysbiosis, and mental health interventions. She has attracted over $15M in funding, including an NHMRC Investigator Grant until 2029. Awards include the University of Adelaide Alumni Award, Australian of the Year Finalist (SA Top 4), and South Australian Tall Poppy of the Year. She supervises 3 staff, 1 postdoc, and 6 HDR students, with a focus on nurturing early-career researchers. Community engagement includes founding pooisnottaboo.com and active roles in patient advocacy through MASCC's Patient Partnership Committee.

• Sport Science
• Environmental Physiology
• Training and Monitoring
• +3 more

Courtney McGowan is a Lecturer in Human Sciences at the Faculty of Health, Southern Cross University. She holds a PhD from the University of Canberra, along with a BCoachingSci and BSportSci(Hons) from the same institution. Her research focuses on enhancing sports performance through competition day preparation strategies, including warm-ups, priming, and thermoregulation. She also explores environmental physiology, elite athlete development, and cognitive strategies to improve athletic performance. Education: PhD in Exercise Science (University of Canberra) BSportSci(Hons) (University of Canberra) BCoachingSci (University of Canberra) Research Interests: Courtney’s work emphasizes competition day strategies (e.g., warm-up optimization, passive heat maintenance), environmental physiology, and the physical preparation of elite athletes. She integrates practical applications for enhancing athlete performance in real-world settings. Teaching & Supervision: She serves as the unit assessor for the course 'Fundamentals of Strength and Conditioning' and supervises students in sports science, physical activity engagement, and health-related research. Community Engagement: Courtney collaborates with organizations like Surfing Tasmania and Cycling Australia to promote sports science and community engagement in athletics. She is an accredited Sports and Exercise Scientist, Strength and Conditioning Coach, and Cycling Coach. Grants & Projects: Her involvement includes the Cornerstone Youth Services Nutrition and Physical Activity Capacity Building Project (2021), focusing on improving health outcomes for young people. She also evaluates innovative technologies like power meters in cycling performance tracking. Labs & Teams: While no specific lab is explicitly mentioned, her affiliations include the broader Faculty of Health’s research networks and Southern Cross University’s infrastructure, including the Environmental Analysis Laboratory and Analytical Research Laboratory.

• Computational Neuroscience
• Neuroimaging
• Connectomics
• +10 more

Professor Michael Breakspear is an internationally recognized leader in computational neuroscience, brain imaging, and translational neurotechnology at the University of Newcastle's School of Psychological Sciences. His research bridges complex systems theory, mathematical modeling, and clinical neuroscience to advance understanding of brain dynamics in health and disease through interdisciplinary collaboration across mathematics, physics, neuroimaging, psychiatry, and artificial intelligence. Professor Breakspear holds a Doctor of Philosophy from the University of Sydney, along with multiple undergraduate degrees including a Bachelor of Medicine and Bachelor of Surgery. His academic journey includes professorial appointments at the University of Sydney (School of Physics), University of Queensland (School of Psychiatry), and University of Western Sydney (School of Psychiatry), where he progressed from Post-doctoral Research Fellow to Associate Professor. Current: Professor, University of Newcastle, School of Psychological Sciences 2017-present: Principal Research Fellow, National Health & Medical Research Council 2017-present: Senior Scientist and Head, QIMR Berghofer Medical Research Institute 2012-2017: Professor (adjunct), University of Sydney, School of Physics 2011-present: Professor (adjunct), University of Queensland, School of Psychiatry 2007-2012: Associate Professor, University of Western Sydney, School of Psychiatry Professor Breakspear's research program integrates expertise across mathematics, physics, neuroimaging, psychiatry, and artificial intelligence. His core expertise includes computational neuroscience (modeling brain dynamics using nonlinear systems theory), neuroimaging and connectomics (pioneering methods to analyze brain networks), brain disorders and mental health (applying computational models to disorders like schizophrenia and bipolar disorder), and neurotechnology and AI (developing machine learning techniques for imaging biomarkers). His recent publications demonstrate a strong focus on brain dynamics, neuroimaging techniques, and applications to psychiatric and neurological disorders. His work spans theoretical frameworks to clinical applications, with particular emphasis on understanding the neural basis of mood disorders, Alzheimer's disease, and psychosis, employing advanced computational approaches to uncover fundamental principles of brain organization and dysfunction. Senior Researcher Award (2017) Principal Research Fellow, National Health & Medical Research Council (2017-present) Professor Breakspear actively collaborates with clinical researchers, engineers, and technology developers to translate theoretical frameworks into practical diagnostic and therapeutic innovations. He provides leadership in training programs at the nexus of neuroscience, mathematics, and data science, fostering the next generation of interdisciplinary researchers through mentorship and collaborative projects that bridge theoretical and clinical domains.

Mike Le PelleyView profile

Professor

• Cognitive Psychology
• Attention
• Learning
• +7 more

Professor Mike Le Pelley is a cognitive psychologist working in the School of Psychology at the University of New South Wales (UNSW). His research program spans multiple domains of cognitive science, focusing on the intersection of mind, brain and behavior. Professor Le Pelley's work aims to characterize the mental processes underlying human cognition and how these processes influence ongoing behavior in both healthy individuals and those with psychiatric conditions. His primary research focus is the relationship between attention and learning. Specifically, he investigates how attention changes as a result of learning about relationships between events. For example, as described in his profile, when driving, individuals prioritize the road ahead while trying to ignore distractions like squabbling children in the back seat. Professor Le Pelley's research examines the mechanisms that govern such attentional prioritization. While the core of his research focuses on fundamental processes in healthy cognition, he also studies how dysfunction in these processes contributes to conditions such as addiction and schizophrenia. His work has significant implications for understanding cognitive processes in both healthy individuals and those with psychiatric conditions. Professor Le Pelley has published extensively on topics including attentional capture by reward-related stimuli, associative learning, and the neural mechanisms underlying cognitive processes. His research frequently employs eye-tracking and neurophysiological methods to examine cognitive processes. His recent publications (2023-2025) demonstrate a clear research trajectory examining how reward systems influence attentional mechanisms. A significant portion of his work investigates how outcome variance, rather than just reward value, modulates attentional priority. His research on inner speech has provided important neurophysiological evidence regarding motor preparation and how this process is disrupted in schizophrenia. Professor Le Pelley's work consistently bridges basic cognitive mechanisms with clinical applications, particularly in understanding addiction and schizophrenia. Professor Le Pelley has made substantial contributions to theoretical frameworks in cognitive psychology, particularly in the areas of associative learning and attention. His 2010 book 'Attention and Associative Learning: From Brain to Behaviour' (co-edited with Chris Mitchell) is a significant contribution to the field. His collaborative work extends across multiple institutions and disciplines, reflecting the interdisciplinary nature of his research.

Miriam MatamalesView profile

Associate Professor

• Neuroscience
• Cognitive Neuroscience
• Systems Neuroscience
• +4 more

Dr. Miriam Matamales is a UNSW Scientia Fellow (Level C) in the School of Psychology at the University of New South Wales. She leads the Neuromodulatory Systems and Behaviour group within the Decision Neuroscience Laboratory, focusing on understanding how neuromodulatory systems support plasticity in subcortical brain networks for generating and modifying voluntary behaviors. Education: Ph.D. Neuroscience, Pierre and Marie Curie University, Paris, France (2009) Master in Biomedical Research, Pompeu Fabra University, Barcelona, Spain (2007) Bachelor of Human Biology, Pompeu Fabra University, Barcelona, Spain (2006) Dr. Matamales' research combines innovative high-throughput fluorescence microscopy and computational image analysis to understand how the functional architecture of the striatum encodes goal-directed learning and how its dysfunction impairs normal behavior. Her work primarily focuses on neuromodulatory systems (dopamine, acetylcholine, neuropeptides) supporting plasticity in subcortical brain networks, particularly the striatum and basal ganglia pathways. She uses mice as experimental models with approaches including instrumental conditioning, AAV-based circuit- and cell-specific tracing and manipulation in behaving animals, in vivo photometry and computational analysis of behavioral and neuronal data. Analysis of Dr. Matamales' recent publications shows a strong focus on striatal function, goal-directed learning mechanisms, and age-related changes in neural circuits. Her work spans from molecular neuroscience examining DARPP-32 signaling to systems-level investigations of basal ganglia circuits and their role in behavior. Scientific Awards: UNSW Dean of Science Early Career Excellence Award (2020) UNSW's Vice-Chancellor's Childcare Support Fund for Women Researchers (2019) Paxinos-Watson Award from the Australasian Neuroscience Society (2017) Dr. Matamales has successfully secured multiple competitive grants including NHMRC Ideas Grants as both Lead CI and CIB, an ARC Discovery Project as Lead Investigator, and a Tourette Association of America Young Investigator Award as sole CI. She currently supervises PhD student Jonathon Jacobs on research related to the molecular footprint of instrumental learning in the striatum. In addition to her research, she teaches in the UNSW NEUR2201 Neuroscience Fundamentals course and serves as invited faculty at the Australasian Course in Advanced Neuroscience. Her laboratory, the Neuromodulatory Systems and Behaviour group (www.neuromodulab.org), investigates how learning is encoded in brain circuits and how new behaviors imprint in neuronal circuits during generation, maturation, and adaptation to environmental rule changes.

Jay Bertran-GonzalezView profile

Associate Professor

• Neuroscience
• Behavioral Neuroscience
• Striatal Circuitry
• +6 more

Associate Professor Jay Bertran-Gonzalez is a faculty member in the School of Psychology at The University of New South Wales (UNSW), where he serves as Director of the Australasian Course in Advanced Neuroscience (ACAN) and Deputy Director of the Decision Neuroscience Laboratory. His work focuses on neuromodulatory systems, striatal circuits, and goal-directed behavior, with particular interests in aging, synaptic plasticity, and dopamine/cholinergic signaling. Education: PhD in Biomedical Research (Université Pierre et Marie Curie, 2010); Master of Biomedical Research (INSERM, 2007); Graduation Project (Universitat Pompeu Fabra, 2006). His research explores how striatal circuits integrate neuromodulatory signals to control action selection, aging-related cognitive decline, and molecular mechanisms of neuroplasticity. Recent work examines lipid signaling in memory and cortico-basal ganglia interactions in behavioral adaptation. Key trends in his 15 most recent articles include striatal neuroplasticity, aging and cognition, GPCR-mediated memory processes, and dopamine-cholinergic interneuron interactions. Collaborative networks span institutions like QBI, Columbia University, and the University of Geneva. Scientific Awards: ARC DECRA (2016), UNSW Dean of Science Early Career Award (2020), Goldstar Award (2018), and more. He has secured significant grants, including NHMRC Ideas Grants (2024, 2023) and ARC Future Fellowship (2021-2024). He teaches NEUR3221 Neurophysiology and PSYC4103, and coordinates ACAN's Systems Neuroscience & Behaviour Theme. As Head of the Neuromodulatory Systems & Behaviour Team and a member of the Australasian Neuroscience Society Council, he bridges research, education, and cross-institutional collaboration.

Prashant BharadwajView profile

Research Fellow

• Alzheimer’s Disease
• Beta amyloid protein
• Autophagy
• +3 more

Dr. Prashant Bharadwaj is a Research Fellow in Neuroscience at Edith Cowan University (ECU) and an Adjunct Research Fellow at Curtin University. He holds a PhD from ECU and specializes in Alzheimer’s disease, autophagy, and neuroprotective strategies. His research focuses on amyloid beta proteins, neurodegenerative mechanisms, and therapeutic interventions. He has been recognized with the NHMRC-ARC Dementia Research Development Fellowship (2016–2022) and a CSIRO travel award. Education: PhD (Edith Cowan University, 2011), Master of Biotechnology (Royal Melbourne Institute of Technology, 2007), Bachelor of Engineering (India, 2004). Research interests include Alzheimer’s pathogenesis, autophagy modulation, and biomarker discovery. Recent work explores polyphenol-rich Sorghum bicolor as a complementary therapy and investigates the role of amylin and beta amyloid interactions. Dr. Bharadwaj has authored over 30 peer-reviewed articles, with contributions to understanding autophagy’s role in amyloid clearance and disease progression. Grants include $640,220 for neuroprotective autophagy research and $250,000 for neurofilament biomarker analysis. He supervises three PhD students as Principal Investigator and collaborates on projects targeting childhood dementia and neuroinflammation.

Paul HodgesView profile

Professor

• Pain
• Motor control
• Rehabilitation
• +4 more

Professor Paul Hodges is a leading academic and researcher in motor control, pain, and rehabilitation at The University of Queensland (UQ). He holds the title of NHMRC Leadership Fellow (Level 3) and serves as Director of the Centre for Innovation in Pain and Health Research (CIPHeR). His interdisciplinary work spans molecular biology to human function, with a focus on understanding pain mechanisms and developing evidence-based treatments. Hodges is a Fellow of the Australian Academy of Science and multiple professional bodies, reflecting his significant contributions to musculoskeletal and clinical science. Education: Doctor of Philosophy (The University of Queensland) Doctor of Philosophy (Karolinska Mediko Kirurgiska Institutet) Doctoral Diploma of Science (Advanced, UQ) Honorary Doctorate in Medicine (Ghent University) Research Interests: Pain mechanisms and targeted therapies Motor control adaptations in musculoskeletal disorders Rehabilitation strategies for chronic pain Pelvic floor dysfunction and continence Low back pain pathophysiology and flares Neuroimmune interactions in chronic pain Awards & Leadership: Five-time ISSLS Prize recipient (Basic and Clinical Science) Fellowships from the Australian Academy of Science and Health and Medical Science Chair of international task forces (e.g., IASP Terminology Task Force) Recipient of national awards including Young Australian of the Year (1997) Research Impact: Hodges' work has transformed understanding of pain-induced motor adaptations, leading to clinical innovations in back pain management, pelvic floor rehabilitation, and continence treatments. His research integrates biomechanical, neurophysiological, and molecular approaches to bridge basic science and clinical practice.

• Epidemiology
• HIV
• Sexually Transmitted Infections
• +4 more

Lei Zhang is a Professor (Research) and Head of the Artificial Intelligence and Modelling in Epidemiology Program at the School of Translational Medicine, Monash University, Australia. He holds adjunct roles at institutions like Tsinghua University and is a consultant to the WHO Western Pacific Region. His expertise spans HIV/STI epidemiology, mathematical modelling, and AI-driven healthcare solutions. Education: Bachelor of Advanced Science in Mathematics (University of Sydney, 2001) Master of Science in Applied Mathematics (University of Sydney, 2003) PhD in Medicine (UNSW, 2006) Master of Public Health (Hamburg University of Applied Sciences, 2009) Research Interests: Prof. Zhang focuses on cross-disciplinary research in HIV/STI epidemiology, AI applications for disease modeling and diagnostics, health economics, and global health policy. His work integrates mathematical models with clinical data to optimize interventions and inform policy. Key Projects: HOPE: Optimizing HIV Pre-Exposure Prophylaxis (PrEP) in East Asia WHO Collaborations: Supporting global STI programs and policy development China-Australia Joint Research Center for Infectious Diseases Awards: 2021 ASRHA Innovation Award for HIV/STI research contributions Advising & Grants: Supervised 21 students (6 PhD, 15 MSc) and currently co-supervises 24 students (11 PhD, 13 MSc). Leader of 5+ major research grants, including NHMRC-funded projects on STI control and diabetes research. Labs/Teams: Leads the AI & Modelling in Epidemiology Program and collaborates with global networks like UNAIDS, the World Bank, and ministries of health across the Western Pacific region.

Stuart RobertsView profile

Academic

• Hepatology
• Chronic Viral Hepatitis
• Primary Liver Cancer
• +9 more

Stuart Roberts is an Adjunct Clinical Professor in the Department of Gastroenterology at Monash University, Faculty of Medicine, Nursing and Health Sciences. He is actively engaged in clinical research focusing on liver diseases, with a strong emphasis on chronic viral hepatitis, primary liver cancer, non-alcoholic fatty liver disease (NAFLD/MASLD), and non-invasive liver diagnostics such as Fibroscan. University: Monash University School: Faculty of Medicine, Nursing and Health Sciences Department: Department of Gastroenterology Academic Rank: Adjunct Clinical Professor His research interests center on advancing therapeutic strategies for chronic liver diseases through clinical trials and translational studies. Key areas include evaluating novel antiviral and immunomodulatory agents for hepatitis B and C, assessing new treatments for hepatocellular carcinoma, and investigating metabolic and dietary influences on liver health in aging populations. He also studies the role of liver stiffness measurement in disease screening and prognosis. The recent publications and active research projects (2024–2025) reflect a strong trend toward understanding the intersection of liver disease with aging, cardiovascular health, and neurocognitive outcomes. His work increasingly focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), its systemic complications, and lifestyle or pharmacological interventions. Multiple phase 1 to phase 3 clinical trials are underway, particularly in NASH/MASH, hepatitis B immunotherapy, and cholangiocarcinoma. Scientific Awards: No awards mentioned in the provided text. Advising and Grants: Dr. Roberts serves as Primary Chief Investigator on 42 research projects, including major industry-sponsored clinical trials in hepatology. His leadership in multicenter studies highlights his role in shaping evidence-based liver disease management. While no formal student advising is mentioned, his collaborations involve trainees and junior researchers. Funding appears to come from pharmaceutical sponsors and institutional sources, supporting trials in antiviral, metabolic, and oncologic liver therapies. Labs and Research Teams: Dr. Roberts leads a clinical research team focused on hepatology within Monash Health. His work is highly collaborative, involving dietitians, oncologists, geriatricians, and neurologists. The research network includes national and international partners, with a strong presence in Australian multicenter liver disease studies.